Literature DB >> 12105099

A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.

A M Pacchioni1, G Gioino, A Assis, L M Cancela.   

Abstract

Evidence indicates that repeated exposure to stressful events sensitizes the motor and addictive effects of drugs of abuse in rats. Regarding a single exposure to one restraint stress, previous findings have shown that it is sufficient to induce behavioral sensitization to stimulating and reinforcing properties of abuse drugs (e.g., amphetamine and morphine), as measured by locomotor activity and conditioned place preference, respectively. It is well known that enhanced dopaminergic neurotransmission in the nucleus accumbens and striatum plays a critical role in the development and/or expression of repeated stress-induced or drug-induced sensitization. In addition, involvement of NMDA receptors has been implicated in its development. However, whether sensitization induced by a single restraint stress exposure represents the same neurobiologic phenomenon is unknown. We studied the following issues: (a) influence of a single restraint exposure on the stimulating effects of amphetamine on dopamine release by microdialysis from striatum and (b) involvement of glutamatergic pathways, specifically those innervating striatum, on stress-induced sensitization to amphetamine, by administering MK-801 ip (0.1 mg/kg) or intrastriatally (1 microg/0.5 microL) previous to an acute restraint stress. For microdialysis studies (a) or intrastriatal administration of MK-801 (b), Wistar rats (250-330 g) were implanted stereotactically under anesthesia with a guide cannula in the striatum. After 2 days, animals were immobilized for 2 hours in a Plexiglas device. Control animals remained in their home cages. The following day we evaluated the stimulating effect of amphetamine on (a) dopamine release from striatum or (b) locomotor activity. In studies (a), dialysis probes were inserted into the guide cannula, and baseline dopamine levels were collected for 2 hours before a challenge of amphetamine (1.5 mg/kg i.p.). Dialysates were then collected by 3 hours. Amphetamine challenge induced a significantly higher increase in dopamine release and locomotor activity in animals previously subjected to one restraint stress exposure, relative to that observed in the no-restraint stress group. MK-801 administered i.p. or intrastriatally blocked the restraint stress-induced sensitization to amphetamine. First, our results point out that a single restraint stress exposure is a pertinent stimulus to induce sensitization of amphetamine's stimulating effects on dopaminergic neurotransmission in the striatum. Secondly, NMDA-glutamatergic receptors, specifically those placed in the striatum, are implicated in the development of stress restraint-induced sensitization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105099     DOI: 10.1111/j.1749-6632.2002.tb04165.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  25 in total

Review 1.  Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system.

Authors:  Fábio C Cruz; Marcelo Tadeu Marin; Rodrigo Molini Leão; Cleopatra S Planeta
Journal:  J Neural Transm (Vienna)       Date:  2011-10-18       Impact factor: 3.575

3.  Repeated social defeat stress-induced sensitization to the locomotor activating effects of d-amphetamine: role of individual differences.

Authors:  D M Dietz; K C Dietz; S Moore; C C Ouimet; M Kabbaj
Journal:  Psychopharmacology (Berl)       Date:  2008-04-16       Impact factor: 4.530

4.  The effects of a single session of inescapable tailshock on the subsequent locomotor response to brief footshock and cocaine administration in rats.

Authors:  Andre Der-Avakian; Robert R Rozeske; Sondra T Bland; Linda R Watkins; Steven F Maier
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

5.  Restraint Stress Potentiated Morphine Sensitization: Involvement of Dopamine Receptors within the Nucleus Accumbens.

Authors:  Elham Charmchi; Golnaz Faramarzi; Mina Rashvand; Morteza Zendehdel; Abbas Haghparast
Journal:  Neurochem Res       Date:  2021-01-03       Impact factor: 3.996

Review 6.  Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.

Authors:  Anthony A Grace
Journal:  Neurotox Res       Date:  2010-02-09       Impact factor: 3.911

7.  Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.

Authors:  Huynh Nhu Mai; Naveen Sharma; Eun-Joo Shin; Bao Trong Nguyen; Ji Hoon Jeong; Choon-Gon Jang; Eun-Hee Cho; Seung Yeol Nah; Nam Hun Kim; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2018-04-23       Impact factor: 3.996

Review 8.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

9.  Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration.

Authors:  Christopher O Boyson; Elizabeth N Holly; Akiko Shimamoto; Lucas Albrechet-Souza; Lindsay A Weiner; Joseph F DeBold; Klaus A Miczek
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

10.  Two modes of intense cocaine bingeing: increased persistence after social defeat stress and increased rate of intake due to extended access conditions in rats.

Authors:  Isabel M H Quadros; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.